Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy.
Pisanu, M E
Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy. [electronic resource] - British journal of cancer Feb 2014 - 625-35 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1532-1827
10.1038/bjc.2013.758 doi
Animals
Cell Line, Tumor
Cisplatin--administration & dosage
Cytostatic Agents--administration & dosage
Female
Gene Expression Regulation, Neoplastic
Humans
Magnetic Resonance Imaging--methods
Magnetic Resonance Spectroscopy--methods
Mice
Ovarian Neoplasms--diagnostic imaging
Radiography
Receptor, ErbB-2--biosynthesis
Xenograft Model Antitumor Assays
Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy. [electronic resource] - British journal of cancer Feb 2014 - 625-35 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1532-1827
10.1038/bjc.2013.758 doi
Animals
Cell Line, Tumor
Cisplatin--administration & dosage
Cytostatic Agents--administration & dosage
Female
Gene Expression Regulation, Neoplastic
Humans
Magnetic Resonance Imaging--methods
Magnetic Resonance Spectroscopy--methods
Mice
Ovarian Neoplasms--diagnostic imaging
Radiography
Receptor, ErbB-2--biosynthesis
Xenograft Model Antitumor Assays